Sunday, August 10, 2025 | 02:07 PM ISTहिंदी में पढें
Data as at IST. Index data may be delayed by up to 20 minutes. For real-time updates, kindly refer to the BSE and NSE websites.
Prism Medico & Pharmacy Ltd
Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.
05:29 PM, 14th Feb 2025
Pursuant to regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we are pleased to inform you that the board of directors at their meeting held today i.e. 14th February 2025 which commenced at 01:30 P.M. and concluded at 05:00 P.M. have inter-alia approved the following: The board considered and approved the Unaudited Standalone financial results of the company for the quarter ended 31st December 2024 along with the Limited Review Report duly signed by the auditors of the company.
